Antiplatelet therapy and Blood creatine phosphokinase mb increased
Summary:
Blood creatine phosphokinase mb increased is found among people with Antiplatelet therapy, especially for people who are male, 60+ old.
The study analyzes which people have Blood creatine phosphokinase mb increased with Antiplatelet therapy. It is created by eHealthMe based on reports of 23 people who have Antiplatelet therapy from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Antiplatelet therapy?
Antiplatelet therapy: no further information found. Check the latest studies of Antiplatelet therapy.
What is Blood creatine phosphokinase mb increased?
Blood creatine phosphokinase mb increased is found to be associated with 301 drugs and 550 conditions by eHealthMe. Check the latest studies of Blood creatine phosphokinase mb increased.
23 people who have Antiplatelet Therapy and Blood Creatine Phosphokinase Mb Increased are studied.

Gender of people who have Antiplatelet Therapy and experienced Blood Creatine Phosphokinase Mb Increased *:
- female: 30 %
- male: 70 %
Age of people who have Antiplatelet Therapy and experienced Blood Creatine Phosphokinase Mb Increased *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 4.76 %
- 50-59: 9.52 %
- 60+: 85.71 %
Common co-existing conditions for these people *:
- Lipids Abnormal: 1 person, 4.35%
- Heart Rate Irregular: 1 person, 4.35%
- Blood Pressure Abnormal: 1 person, 4.35%
- Anaesthesia: 1 person, 4.35%
Common drugs taken by these people *:
- Integrilin: 17 people, 73.91%
- Pepcid: 15 people, 65.22%
- Aspirin: 14 people, 60.87%
- Fentanyl: 11 people, 47.83%
- Heparin: 10 people, 43.48%
- Nitroglycerin: 10 people, 43.48%
- Clopidogrel Bisulfate: 9 people, 39.13%
- Cefazolin: 8 people, 34.78%
- Morphine: 6 people, 26.09%
- Plavix: 3 people, 13.04%
Common symptoms for these people *:
- Drug Ineffective: 10 people, 43.48%
- Blood Creatine Phosphokinase Increased: 7 people, 30.43%
- Post Procedural Complication: 5 people, 21.74%
- Chest Pain: 4 people, 17.39%
- Heart Attack: 3 people, 13.04%
- Catheter Site Haemorrhage (bleeding at catheter site): 3 people, 13.04%
- Post Procedural Haemorrhage (post procedural bleeding): 3 people, 13.04%
- Acute Myocardial Infarction (acute heart attack): 2 people, 8.70%
- Electrocardiogram Abnormal: 2 people, 8.70%
- Troponin I Increased: 2 people, 8.70%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Blood creatine phosphokinase mb increased?
- Check whether Blood creatine phosphokinase mb increased is associated with a drug or a conditionRelated studies:
Treatments, associated drugs and conditions:
- Antiplatelet therapy (11,535 reports)
- Blood creatine phosphokinase mb increased (2,506 reports)
All the drugs that are associated with Blood creatine phosphokinase mb increased:
- Blood creatine phosphokinase mb increased (301 drugs)
All the conditions that are associated with Blood creatine phosphokinase mb increased:
- Blood creatine phosphokinase mb increased (550 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Blood creatine phosphokinase mb increased and Antiplatelet therapy, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Loraz and Ephedrine Sulfate - 3 seconds ago
- Could Exforge cause Pancreatitis Aggravated? - 15 seconds ago
- Drug interactions of Chantix and Avandaryl - 26 seconds ago
- Drug interactions of Zyloprim and Neupogen - 26 seconds ago
- Drug interactions of Veletri and Lanoxin - 29 seconds ago
- Drug interactions of Xeljanz Xr and Salagen - 32 seconds ago
- Drug interactions of Cholestyramine and Metoclopramide - 39 seconds ago
- Staphylococcal Infection and Pain Exacerbated - 47 seconds ago
- Could Zantac cause Blood Glucose Increased? - 57 seconds ago
- Drug interactions of Floxin and Omeprazole - a minute ago